Delivery Order SPE2DB22D1106-SPE2DB24FDSB0
- Not listed
- This federal contract award is for the delivery of 4,563,284,097 units of Zolmitriptan 5 mg nasal spray to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,615.41, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 9, 2024. The contract has an ultimate completion date of January 10, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of Zolmitriptan 5 mg Nasal Spray in quantities of 6 per package to the Defense Logistics Agency (DLA). The contract, valued at $6,486.22, was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price, and the ultimate completion date is June 5, 2024. This contract award is not associated with a set-aside designation....
- This federal contract award is for the delivery of Zolmitriptan 5 mg nasal spray to the Defense Logistics Agency (DLA), a defense agency. The $2,042.23 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,322.77 firm-fixed-price delivery order is for the supply of Zolmitriptan 5 mg nasal spray, with a period of performance through October 28, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- The federal contract award is for the delivery of Zolmitriptan 5 mg nasal spray to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a Firm Fixed Price delivery order contract with a ceiling value of $9,843.83 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,586.72 Firm Fixed Price Delivery Order covers the supply of Zolmitriptan 5 mg Nasal Spray. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,811.39 firm fixed-price delivery order is for the supply of Zolmitriptan 5 mg nasal spray, a prescription medication. The contract has an ultimate completion date of May 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation is for the delivery of Zolmitriptan 5 mg nasal spray. The $66,221.88 firm fixed-price delivery order has a completion date of January 24, 2025. The award is not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, valued at $11,212.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zolmitriptan 5 mg nasal spray, a medical product used for the treatment of migraines. The contract has an ultimate completion date of July 10, 2024 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $14,720.75 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 4564042929 ZOLMITRIPTAN 5 MG NASAL SPRAY 6S, a pharmaceutical product, with a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDSB0Delivery Order
This federal contract award is for the delivery of Zolmitriptan 5 mg nasal spray to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $13,760.98 and an ultimate completion date of December 26, 2023. The contract was awarded on December 22, 2023 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 12/22/23 |